Ozempic / Mounjaro vs Generic Peptides
Is generic semaglutide or tirzepatide just as effective as the brand-name version? Here's what you need to know.
What's the Difference?
Ozempic and Wegovy are brand-name versions of semaglutide made by Novo Nordisk. Mounjaro and Zepbound are brand-name tirzepatide made by Eli Lilly. These are FDA-approved, pharmaceutical-grade formulations sold through licensed pharmacies at significant cost ($800–1,200/month without insurance in the US).
Generic or research-grade versions contain the identical active molecule — the same amino acid sequence and chemical structure. The difference lies in manufacturing standards, inactive ingredients (excipients), and the regulatory oversight applied during production.
Brand vs Generic: Side-by-Side
| Factor | Brand (Ozempic/Mounjaro) | Generic/Research Grade |
|---|---|---|
| Active molecule | Identical | Identical |
| FDA approval | Yes | No (research use) |
| Manufacturing oversight | GMP certified | Varies by supplier |
| Price (Vietnam) | ~$800–1,200/month | ~$138–205/month |
| COA verification | Pharmacy-issued | Third-party lab (must request) |
| Availability | Pharmacy (requires Rx) | Online suppliers |
| Formulation | Pen injector | Lyophilized vial |
Is Generic Safe?
Generic research-grade peptides can be safe when sourced from a reputable supplier with third-party COA verification. The key risks are:
- ⚠Underdosing: vial contains less than labeled (you get no results but think it doesn't work)
- ⚠Contamination: improper manufacturing introduces impurities
- ⚠Wrong compound: product is substituted or mislabeled
- ⚠Improper storage: degradation before you receive it
These risks are substantially mitigated by using a COA-verified supplier with cold-chain shipping. Many users in Vietnam and internationally report equivalent results from generic vs brand-name versions when sourced responsibly.